|
|
|
|
|
|
|
|
|
|
Future Medicine
Special Report
Heart failure years after cancer treatment
Progress
in cancer treatment has significantly improved survival of patients
with cancer. However, the incidence of cardiovascular diseases such as
left ventricular dysfunction (LVD) and chronic heart failure (HF) is
increasing due to the long-term toxic effects of chemotherapy and
radiotherapy. Cardio-oncology teams are necessary to ensure the
implementation of primary prevention strategies and screening protocols
for early recognition of LVD. Moreover, early administration of advanced
treatment for HF is crucial to achieve left ventricular recovery. In
this article we will focus on the prevalence of chronic HF among cancer
survivors, the main risk factors of LVD and chronic HF, the prevention
strategies and management based on the current evidence and, finally,
the future perspectives in this field.
Cited by
Ellen Clarke, Daniel Lenihan. (2015) Cardio-oncology: a new discipline in medicine to lead us into truly integrative care. Future Cardiology 11:4, 359-361.
Online publication date: 1-Jul-201513-Aug-2015. Citation | Full Text | PDF (1950 KB) | PDF Plus (1964 KB) | Reprints & Permissions Users who read this article also read:
|
|
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.